{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Acute exacerbation", "Air pollution exposure", "Idiopathic pulmonary fibrosis", "Particulate matter", "Risk factors"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "33711988", "DateCompleted": {"Year": "2021", "Month": "11", "Day": "05"}, "DateRevised": {"Year": "2021", "Month": "11", "Day": "05"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2021", "Month": "03", "Day": "12"}], "ELocationID": ["80", "10.1186/s12931-021-01671-6"], "Journal": {"ISSN": "1465-993X", "JournalIssue": {"Volume": "22", "Issue": "1", "PubDate": {"Year": "2021", "Month": "Mar", "Day": "12"}}, "Title": "Respiratory research", "ISOAbbreviation": "Respir Res"}, "ArticleTitle": "Exposure to PM<sub>2.5</sub> is a risk factor for acute exacerbation of surgically diagnosed idiopathic pulmonary fibrosis: a case-control study.", "Pagination": {"StartPage": "80", "MedlinePgn": "80"}, "Abstract": {"AbstractText": ["Short-term exposure to ozone and nitrogen dioxide is a risk factor for acute exacerbation (AE) of idiopathic pulmonary fibrosis (AE-IPF). The comprehensive roles of exposure to fine particulate matter in AE-IPF remain unclear. We aim to investigate the association of short-term exposure to fine particulate matter with the incidence of AE-IPF and to determine the exposure-risk time window during 3\u00a0months before the diagnosis of AE-IPF.", "IPF patients were retrospectively identified from the nationwide registry in Japan. We conducted a case-control study to assess the correlation between AE-IPF incidence and short-term exposure to eight air pollutants, including particulate matter\u2009<\u20092.5\u00a0\u00b5m (PM<sub>2.5</sub>). In the time-series data, we compared monthly mean exposure concentrations between months with AE (case months) and those without AE (control months). We used multilevel mixed-effects logistic regression models to consider individual and institutional-level variables, and also adjusted these models for several covariates, including temperature and humidity. An additional analysis with different monthly lag periods was conducted to determine the risk-exposure time window for 3\u00a0months before the diagnosis of AE-IPF.", "Overall, 152 patients with surgically diagnosed IPF were analyzed. AE-IPF was significantly associated with an increased mean exposure level of nitric oxide (NO) and PM<sub>2.5</sub> 30\u00a0days prior to AE diagnosis. Adjusted odds ratio (OR) with a 10 unit increase in NO was 1.46 [95% confidence interval (CI) 1.11-1.93], and PM<sub>2.5</sub> was 2.56 (95% CI 1.27-5.15). Additional analysis revealed that AE-IPF was associated with exposure to NO during the lag periods lag 1, lag 2, lag 1-2, and lag 1-3, and PM<sub>2.5</sub> during the lag periods lag 1 and lag 1-2.", "Our results show that PM<sub>2.5</sub> is a risk factor for AE-IPF, and the risk-exposure time window related to AE-IPF may lie within 1-2\u00a0months before the AE diagnosis. Further investigation is needed on the novel findings regarding the exposure to NO and AE-IPF."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Respiratory Medicine, University of Occupational and Environmental Health, Japan, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu-city, Fukuoka, 807-8555, Japan."}], "LastName": "Tahara", "ForeName": "Masahiro", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Environmental Epidemiology, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan."}], "LastName": "Fujino", "ForeName": "Yoshihisa", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Respiratory Medicine, University of Occupational and Environmental Health, Japan, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu-city, Fukuoka, 807-8555, Japan."}], "LastName": "Yamasaki", "ForeName": "Kei", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Respiratory Medicine, University of Occupational and Environmental Health, Japan, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu-city, Fukuoka, 807-8555, Japan."}], "LastName": "Oda", "ForeName": "Keishi", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Respiratory Medicine, University of Occupational and Environmental Health, Japan, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu-city, Fukuoka, 807-8555, Japan."}, {"Identifier": [], "Affiliation": "Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan."}], "LastName": "Kido", "ForeName": "Takashi", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan."}], "LastName": "Sakamoto", "ForeName": "Noriho", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Respiratory Medicine, University of Occupational and Environmental Health, Japan, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu-city, Fukuoka, 807-8555, Japan."}], "LastName": "Kawanami", "ForeName": "Toshinori", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan."}], "LastName": "Kataoka", "ForeName": "Kensuke", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Radiology, Faculty of Medicine, Saga University, Saga, Japan."}], "LastName": "Egashira", "ForeName": "Ryoko", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan."}], "LastName": "Hashisako", "ForeName": "Mikiko", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan."}], "LastName": "Suzuki", "ForeName": "Yuzo", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan."}], "LastName": "Fujisawa", "ForeName": "Tomoyuki", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan."}], "LastName": "Mukae", "ForeName": "Hiroshi", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan."}], "LastName": "Suda", "ForeName": "Takafumi", "Initials": "T"}, {"Identifier": ["0000-0002-2955-4432"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Respiratory Medicine, University of Occupational and Environmental Health, Japan, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu-city, Fukuoka, 807-8555, Japan. yatera@med.uoeh-u.ac.jp."}], "LastName": "Yatera", "ForeName": "Kazuhiro", "Initials": "K"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Respir Res", "NlmUniqueID": "101090633", "ISSNLinking": "1465-9921"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Air Pollutants"}, {"RegistryNumber": "0", "NameOfSubstance": "Particulate Matter"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": ["adverse effects", "analysis"], "DescriptorName": "Air Pollutants"}, {"QualifierName": [], "DescriptorName": "Case-Control Studies"}, {"QualifierName": [], "DescriptorName": "Cross-Over Studies"}, {"QualifierName": ["adverse effects", "analysis"], "DescriptorName": "Environmental Exposure"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Follow-Up Studies"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["diagnosis", "epidemiology", "surgery"], "DescriptorName": "Idiopathic Pulmonary Fibrosis"}, {"QualifierName": ["epidemiology"], "DescriptorName": "Japan"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["adverse effects", "analysis"], "DescriptorName": "Particulate Matter"}, {"QualifierName": [], "DescriptorName": "Retrospective Studies"}, {"QualifierName": [], "DescriptorName": "Risk Factors"}], "CoiStatement": "MT received grants from GlaxoSmithKline and speakers\u2019 fees from Boehringer Ingelheim and MSD, all outside the submitted work. YF received grants from Hitachi Systems, Ltd. and NIPPON STEEL CORPORATION and personal fees from Asahi Kasei, The Asahi Shimbun Company, AstraZeneca, CHUGAI, NTT DATA MSE CORPORATION, Pfizer, Sompo Health Support Inc., and THE LOFT CO., LTD., all outside the submitted work. KY received speakers\u2019 fees from Novartis outside the submitted work. TK received speakers\u2019 fees from Asahi Kasei, AstraZeneca, Boehringer Ingelheim, and TEIJIN outside the submitted work. NS received consultancy or speakers\u2019 fees from Boehringer Ingelheim, CHUGAI, and Daiichi Sankyo outside the submitted work. TK received speakers\u2019 fees from KYORIN outside the submitted work. KK received speakers\u2019 fees from Boehringer Ingelheim outside the submitted work. RE received grants from the Japan Society for the Promotion of Science and speakers\u2019 fees from AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo, EISAI, KYORIN, and SHIONOGI, all outside the submitted work. YS received grants from the Japan Society for the Promotion of Science and the Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care, as well as received industry-academic funding from MSD and Novartis, all outside the submitted work. HM received industry-academic funding from Asahi Kasei, Astellas, Boehringer Ingelheim, CHUGAI, Daiichi Sankyo, EISAI, Eli Lilly, Fujifilm, GlaxoSmithKline, KYORIN, Meiji Seika, MSD, Novartis, ONO PHARMACEUTICAL CO., LTD., Oxford Immunotec, Inc., Pfizer, SHIONOGI, Sumitomo Dainippon, TAIHO, TAISHO, Takeda, TEIJIN, TORAY, TORII, Toyama Chemical, and Yakult, as well as consultancy or speakers\u2019 fees from Abbott, Asahi Kasei, Astellas, AstraZeneca, Boehringer Ingelheim, Bristol-Myers, CHUGAI, Daiichi Sankyo, Denka Seiken, Eli Lilly, Fujifilm, GlaxoSmithKline, KYORIN, Meiji Seika, MSD, Mylan, Nihon Pharmaceutical, Nikkei Radio, Novartis, ONO, Pfizer, SHIONOGI, Sumitomo Dainippon, TAIHO, TAISHO, TEIJIN, TORAY, and Toyama Chemical, all outside the submitted work. TS received industry-academic funding from Astellas, AstraZeneca, Boehringer Ingelheim, Bristol-Myers, CHUGAI, Eli Lilly, Daiichi Sankyo, KYORIN, MITSUBISHI, MSD, Novartis, ONO, Pfizer, Sanofi, SHIONOGI, TAIHO, TAISHO, Taisho Toyama, Takeda, TANABE, and TEIJIN, as well as consultancy or speakers\u2019 fees from Astellas, AstraZeneca, Boehringer Ingelheim, CHUGAI, Eli Lilly, KYORIN, Daiichi Sankyo, SHIONOGI, MSD, Novartis, ONO, Pfizer, TAISHO, Taisho Toyama, and Tanabe Mitsubishi, all outside the submitted work. KY received industry-academic funding from Boehringer Ingelheim, GlaxoSmithKline, KYORIN, MSD, Novartis, ONO, Pfizer, TAIHO, TAISHO, and TEIJIN, as well as consultancy or speakers\u2019 fees from Asahi Kasei, Astellas, AstraZeneca, Boehringer Ingelheim, Bristol-Myers, CHUGAI, Daiichi Sankyo, Eli Lilly, GlaxoSmithKline, KYORIN, MSD, Novartis, ONO, Pfizer, SHIONOGI, TAIHO, TAISHO, TEIJIN, and TOA EIYO LTD., all outside the submitted work. The other authors declare they have no actual or potential competing financial interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788\u2013824. doi: 10.1164/rccm.2009-040GL.", "ArticleIdList": ["10.1164/rccm.2009-040GL", "PMC5450933", "21471066"]}, {"Citation": "King TE, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet. 2011;378:1949\u20131961. doi: 10.1016/S0140-6736(11)60052-4.", "ArticleIdList": ["10.1016/S0140-6736(11)60052-4", "21719092"]}, {"Citation": "Natsuizaka M, Chiba H, Kuronuma K, Otsuka M, Kudo K, Mori M, Bando M, Sugiyama Y, Takahashi H. Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences. Am J Respir Crit Care Med. 2014;190:773\u2013779. doi: 10.1164/rccm.201403-0566OC.", "ArticleIdList": ["10.1164/rccm.201403-0566OC", "25162152"]}, {"Citation": "Sese L, Nunes H, Cottin V, Sanyal S, Didier M, Carton Z, Israel-Biet D, Crestani B, Cadranel J, Wallaert B, et al. Role of atmospheric pollution on the natural history of idiopathic pulmonary fibrosis. Thorax. 2018;73:145\u2013150. doi: 10.1136/thoraxjnl-2017-209967.", "ArticleIdList": ["10.1136/thoraxjnl-2017-209967", "28798214"]}, {"Citation": "King TE, Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2083\u20132092. doi: 10.1056/NEJMoa1402582.", "ArticleIdList": ["10.1056/NEJMoa1402582", "24836312"]}, {"Citation": "Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2071\u20132082. doi: 10.1056/NEJMoa1402584.", "ArticleIdList": ["10.1056/NEJMoa1402584", "24836310"]}, {"Citation": "Jo HE, Glaspole I, Grainge C, Goh N, Hopkins PM, Moodley Y, Reynolds PN, Chapman S, Walters EH, Zappala C, et al. Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry. Eur Respir J. 2017 doi: 10.1183/13993003.01592-2016.", "ArticleIdList": ["10.1183/13993003.01592-2016", "28232409"]}, {"Citation": "Guenther A, Krauss E, Tello S, Wagner J, Paul B, Kuhn S, Maurer O, Heinemann S, Costabel U, Barbero MAN, et al. The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis. Respir Res. 2018;19:141. doi: 10.1186/s12931-018-0845-5.", "ArticleIdList": ["10.1186/s12931-018-0845-5", "PMC6064050", "30055613"]}, {"Citation": "Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE, Jr, Lasky JA, Loyd JE, Noth I, Olman MA, et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2007;176:636\u2013643. doi: 10.1164/rccm.200703-463PP.", "ArticleIdList": ["10.1164/rccm.200703-463PP", "PMC2094133", "17585107"]}, {"Citation": "Collard HR, Ryerson CJ, Corte TJ, Jenkins G, Kondoh Y, Lederer DJ, Lee JS, Maher TM, Wells AU, Antoniou KM, et al. Acute exacerbation of idiopathic pulmonary fibrosis. An International Working Group Report. Am J Respir Crit Care Med. 2016;194:265\u2013275. doi: 10.1164/rccm.201604-0801CI.", "ArticleIdList": ["10.1164/rccm.201604-0801CI", "27299520"]}, {"Citation": "Wootton SC, Kim DS, Kondoh Y, Chen E, Lee JS, Song JW, Huh JW, Taniguchi H, Chiu C, Boushey H, et al. Viral infection in acute exacerbation of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;183:1698\u20131702. doi: 10.1164/rccm.201010-1752OC.", "ArticleIdList": ["10.1164/rccm.201010-1752OC", "PMC3136996", "21471095"]}, {"Citation": "Lee JS, Song JW, Wolters PJ, Elicker BM, King TE, Jr, Kim DS, Collard HR. Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis. Eur Respir J. 2012;39:352\u2013358. doi: 10.1183/09031936.00050911.", "ArticleIdList": ["10.1183/09031936.00050911", "PMC5529033", "22183478"]}, {"Citation": "Kondoh Y, Taniguchi H, Kitaichi M, Yokoi T, Johkoh T, Oishi T, Kimura T, Nishiyama O, Kato K, du Bois RM. Acute exacerbation of interstitial pneumonia following surgical lung biopsy. Respir Med. 2006;100:1753\u20131759. doi: 10.1016/j.rmed.2006.02.002.", "ArticleIdList": ["10.1016/j.rmed.2006.02.002", "16584880"]}, {"Citation": "Johannson KA, Vittinghoff E, Lee K, Balmes JR, Ji W, Kaplan GG, Kim DS, Collard HR. Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure. Eur Respir J. 2014;43:1124\u20132113. doi: 10.1183/09031936.00122213.", "ArticleIdList": ["10.1183/09031936.00122213", "PMC5555605", "24176998"]}, {"Citation": "Brunekreef B, Holgate ST. Air pollution and health. Lancet. 2002;360:1233\u20131242. doi: 10.1016/S0140-6736(02)11274-8.", "ArticleIdList": ["10.1016/S0140-6736(02)11274-8", "12401268"]}, {"Citation": "Dominici F, Peng RD, Bell ML, Pham L, McDermott A, Zeger SL, Samet JM. Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. JAMA. 2006;295:1127\u20131134. doi: 10.1001/jama.295.10.1127.", "ArticleIdList": ["10.1001/jama.295.10.1127", "PMC3543154", "16522832"]}, {"Citation": "Atkinson RW, Kang S, Anderson HR, Mills IC, Walton HA. Epidemiological time series studies of PM2.5 and daily mortality and hospital admissions: a systematic review and meta-analysis. Thorax. 2014;69:660\u2013665. doi: 10.1136/thoraxjnl-2013-204492.", "ArticleIdList": ["10.1136/thoraxjnl-2013-204492", "PMC4078677", "24706041"]}, {"Citation": "Li MH, Fan LC, Mao B, Yang JW, Choi AMK, Cao WJ, Xu JF. Short-term exposure to ambient fine particulate matter increases hospitalizations and mortality in COPD: a systematic review and meta-analysis. Chest. 2016;149:447\u2013458. doi: 10.1378/chest.15-0513.", "ArticleIdList": ["10.1378/chest.15-0513", "26111257"]}, {"Citation": "Dales R, Blanco-Vidal C, Cakmak S. The association between air pollution and hospitalization of patients with idiopathic pulmonary fibrosis in chile: a daily time series analysis. Chest. 2020;158:630\u2013636. doi: 10.1016/j.chest.2020.02.017.", "ArticleIdList": ["10.1016/j.chest.2020.02.017", "32092324"]}, {"Citation": "Fujisawa T, Mori K, Mikamo M, Ohno T, Kataoka K, Sugimoto C, Kitamura H, Enomoto N, Egashira R, Sumikawa H, et al. Nationwide cloud-based integrated database of idiopathic interstitial pneumonias for multidisciplinary discussion. Eur Respir J. 2019;53:1802243. doi: 10.1183/13993003.02243-2018.", "ArticleIdList": ["10.1183/13993003.02243-2018", "PMC6853800", "30880283"]}, {"Citation": "Diez-Roux AV. Multilevel analysis in public health research. Annu Rev Public Health. 2000;21:171\u2013192. doi: 10.1146/annurev.publhealth.21.1.171.", "ArticleIdList": ["10.1146/annurev.publhealth.21.1.171", "10884951"]}, {"Citation": "Navidi W, Thomas D, Stram D, Peters J. Design and analysis of multilevel analytic studies with applications to a study of air pollution. Environ Health Perspect. 1994;102(Suppl 8):25\u201332. doi: 10.1289/ehp.94102s825.", "ArticleIdList": ["10.1289/ehp.94102s825", "PMC1566539", "7851327"]}, {"Citation": "Carracedo-Martinez E, Taracido M, Tobias A, Saez M, Figueiras A. Case-crossover analysis of air pollution health effects: a systematic review of methodology and application. Environ Health Perspect. 2010;118:1173\u20131182. doi: 10.1289/ehp.0901485.", "ArticleIdList": ["10.1289/ehp.0901485", "PMC2920078", "20356818"]}, {"Citation": "American Thoracic S, European Respiratory S: American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002;165:277\u2013304.", "ArticleIdList": ["11790668"]}, {"Citation": "Travis WD, Costabel U, Hansell DM, King TE, Jr., Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, et al: An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. 2013;188:733\u2013748", "ArticleIdList": ["PMC5803655", "24032382"]}, {"Citation": "Song JW, Hong SB, Lim CM, Koh Y, Kim DS. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur Respir J. 2011;37:356\u2013363. doi: 10.1183/09031936.00159709.", "ArticleIdList": ["10.1183/09031936.00159709", "20595144"]}, {"Citation": "Bowe B, Xie Y, Yan Y, Al-Aly Z. Burden of cause-specific mortality associated with PM2.5 air pollution in the United States. JAMA Netw Open. 2019;2:e1915834. doi: 10.1001/jamanetworkopen.2019.15834.", "ArticleIdList": ["10.1001/jamanetworkopen.2019.15834", "PMC6902821", "31747037"]}, {"Citation": "Falcon-Rodriguez CI, Osornio-Vargas AR, Sada-Ovalle I, Segura-Medina P. Aeroparticles, composition, and lung diseases. Front Immunol. 2016;7:3. doi: 10.3389/fimmu.2016.00003.", "ArticleIdList": ["10.3389/fimmu.2016.00003", "PMC4719080", "26834745"]}, {"Citation": "Nel AE, Diaz-Sanchez D, Ng D, Hiura T, Saxon A. Enhancement of allergic inflammation by the interaction between diesel exhaust particles and the immune system. J Allergy Clin Immunol. 1998;102:539\u2013554. doi: 10.1016/S0091-6749(98)70269-6.", "ArticleIdList": ["10.1016/S0091-6749(98)70269-6", "9802360"]}, {"Citation": "Nel A. Atmosphere. Air pollution-related illness: effects of particles. Science. 2005;308:804\u2013806. doi: 10.1126/science.1108752.", "ArticleIdList": ["10.1126/science.1108752", "15879201"]}, {"Citation": "Gilliland FD, Li YF, Saxon A, Diaz-Sanchez D. Effect of glutathione-S-transferase M1 and P1 genotypes on xenobiotic enhancement of allergic responses: randomised, placebo-controlled crossover study. Lancet. 2004;363:119\u2013125. doi: 10.1016/S0140-6736(03)15262-2.", "ArticleIdList": ["10.1016/S0140-6736(03)15262-2", "14726165"]}, {"Citation": "Mukae H, Vincent R, Quinlan K, English D, Hards J, Hogg JC, van Eeden SF. The effect of repeated exposure to particulate air pollution (PM10) on the bone marrow. Am J Respir Crit Care Med. 2001;163:201\u2013209. doi: 10.1164/ajrccm.163.1.2002039.", "ArticleIdList": ["10.1164/ajrccm.163.1.2002039", "11208647"]}, {"Citation": "North CM, Rice MB, Ferkol T, Gozal D, Hui C, Jung SH, Kuribayashi K, McCormack MC, Mishima M, Morimoto Y, et al. Air pollution in the Asia-Pacific Region: A Joint Asian Pacific Society of Respirology/American Thoracic Society perspective (Republication) Respirology. 2019;24:484\u2013491. doi: 10.1111/resp.13531.", "ArticleIdList": ["10.1111/resp.13531", "30920029"]}, {"Citation": "Europe, W. H. O. R. O. for & Organization, W. H. Air Quality Guidelines: Global update 2005: Particulate matter, ozone, nitrogen dioxide and sulfur dioxide. World Health Organization, 2006", "ArticleIdList": ["34662007"]}, {"Citation": "Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, Behr J, Cottin V, Danoff SK, Morell F, et al. Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018;198:44\u201368. doi: 10.1164/rccm.201807-1255ST.", "ArticleIdList": ["10.1164/rccm.201807-1255ST", "30168753"]}, {"Citation": "Raghu G, Mageto YN, Lockhart D, Schmidt RA, Wood DE, Godwin JD. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: a prospective study. Chest. 1999;116:1168\u20131174. doi: 10.1378/chest.116.5.1168.", "ArticleIdList": ["10.1378/chest.116.5.1168", "10559072"]}, {"Citation": "Hunninghake GW, Zimmerman MB, Schwartz DA, King TE, Jr, Lynch J, Hegele R, Waldron J, Colby T, Muller N, Lynch D, et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2001;164:193\u2013196. doi: 10.1164/ajrccm.164.2.2101090.", "ArticleIdList": ["10.1164/ajrccm.164.2.2101090", "11463586"]}, {"Citation": "Lederer DJ, Martinez FJ. Idiopathic pulmonary fibrosis. N Engl J Med. 2018;378:1811\u20131823. doi: 10.1056/NEJMra1705751.", "ArticleIdList": ["10.1056/NEJMra1705751", "29742380"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "12", "Day": "2"}, {"Year": "2021", "Month": "2", "Day": "24"}, {"Year": "2021", "Month": "3", "Day": "13", "Hour": "5", "Minute": "28"}, {"Year": "2021", "Month": "3", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "11", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "12"}], "PublicationStatus": "epublish", "ArticleIdList": ["33711988", "PMC7955640", "10.1186/s12931-021-01671-6", "10.1186/s12931-021-01671-6"]}}], "PubmedBookArticle": []}